Australia's most trusted
source of pharma news
Posted 1 July 2026 PM
Canada-headquartered Klick Health has acquired communications consultancy Oxford PharmaGenesis, the latest in a series of moves to expand its medical and market access capabilities and strengthen its global presence.
While the financials of the buyout have not been disclosed, the deal will bring together Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick’s strength in commercial strategy, medical creative, digital analytics and experience design to “deliver an unparalleled scientific-to-commercial experience”, according to the companies.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.